Literature DB >> 26149195

Identifying racial differences in nodular lymphocyte-predominant Hodgkin lymphoma.

Christopher R Flowers1, Loretta J Nastoupil2.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 26149195      PMCID: PMC4575619          DOI: 10.1002/cncr.29526

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  18 in total

1.  Racial differences in presentation and management of follicular non-Hodgkin lymphoma in the United States: report from the National LymphoCare Study.

Authors:  Chadi Nabhan; Michelle Byrtek; Michael D Taylor; Jonathan W Friedberg; James R Cerhan; John D Hainsworth; Thomas P Miller; Jamie Hirata; Brian K Link; Christopher R Flowers
Journal:  Cancer       Date:  2012-03-20       Impact factor: 6.860

2.  Disparities in the early adoption of chemoimmunotherapy for diffuse large B-cell lymphoma in the United States.

Authors:  Christopher R Flowers; Stacey A Fedewa; Amy Y Chen; Loretta J Nastoupil; Joseph Lipscomb; Otis W Brawley; Elizabeth M Ward
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-07-06       Impact factor: 4.254

Review 3.  Lymphocyte-predominant Hodgkin lymphoma: what is the optimal treatment?

Authors:  Michelle Fanale
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2013

Review 4.  Nodular lymphocyte predominant hodgkin lymphoma: biology, diagnosis and treatment.

Authors:  Anupama Goel; Wen Fan; Amit A Patel; Madhuri Devabhaktuni; Michael L Grossbard
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2014-02-03

5.  Racial differences in the presentation and outcomes of chronic lymphocytic leukemia and variants in the United States.

Authors:  Pareen J Shenoy; Neha Malik; Rajni Sinha; Ajay Nooka; Loretta J Nastoupil; Melody Smith; Christopher R Flowers
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2011-09-01

6.  Examining racial differences in diffuse large B-cell lymphoma presentation and survival.

Authors:  Christopher R Flowers; Pareen J Shenoy; Uma Borate; Kevin Bumpers; Tanyanika Douglas-Holland; Nassoma King; Otis W Brawley; Joseph Lipscomb; Mary Jo Lechowicz; Rajni Sinha; Rajinder S Grover; Leon Bernal-Mizrachi; Jeanne Kowalski; Will Donnellan; Angelina The; Vishnu Reddy; David L Jaye; James Foran
Journal:  Leuk Lymphoma       Date:  2013-02

7.  How I treat nodular lymphocyte predominant Hodgkin lymphoma.

Authors:  Ranjana H Advani; Richard T Hoppe
Journal:  Blood       Date:  2013-11-08       Impact factor: 22.113

8.  Racial differences in the presentation and outcomes of diffuse large B-cell lymphoma in the United States.

Authors:  Pareen J Shenoy; Neha Malik; Ajay Nooka; Rajni Sinha; Kevin C Ward; Otis W Brawley; Joseph Lipscomb; Christopher R Flowers
Journal:  Cancer       Date:  2010-12-22       Impact factor: 6.860

9.  Mature results of a phase II study of rituximab therapy for nodular lymphocyte-predominant Hodgkin lymphoma.

Authors:  Ranjana H Advani; Sandra J Horning; Richard T Hoppe; Sarah Daadi; John Allen; Yasodha Natkunam; Nancy L Bartlett
Journal:  J Clin Oncol       Date:  2014-02-10       Impact factor: 44.544

10.  Insurance status is related to diffuse large B-cell lymphoma survival.

Authors:  Xuesong Han; Ahmedin Jemal; Christopher R Flowers; Helmneh Sineshaw; Loretta J Nastoupil; Elizabeth Ward
Journal:  Cancer       Date:  2014-01-28       Impact factor: 6.860

View more
  1 in total

1.  Characterizing Lymphoma Incidence and Disparities for a Cancer Center Catchment Region.

Authors:  Amy A Ayers; Lin Lyu; Kaylin Dance; Kevin C Ward; Christopher R Flowers; Jean L Koff; Lauren E McCullough
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2019-06-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.